Estée Lauder Companies completes acquisition of DECIEM
Estée Lauder Companies (ELC) has completed its acquisition of DECIEM Beauty Group as it looks to expand its skincare portfolio.
Known as The Abnormal Beauty Company, DECIEM’s brands include The Ordinary, NIOD and Hylamide.
ELC first invested in the company in 2017 then increased its stake to become majority owner in 2021. It recently exercised its option to purchase the remaining interests in DECIEM after a three-year period.
The company closed on the purchase on 31 May for an estimated $860 million. The total investment, net of cash, was approximately $1.7 billion over the three tranches.
Fabrizio Freda, president and chief executive officer of ELC, said: “In our seven years of partnership, DECIEM has achieved impressive growth while continuing its core mission of reimagining effective, high-quality skin care for today’s diverse and sophisticated consumers.
“As a digitally native organization with a highly engaged following among millennial and Gen Z consumers, DECIEM helps to strategically expand our skin care portfolio, and we believe there are many more exciting growth opportunities ahead.”
